SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

DOGI is gaining traction as a prominent DRC-20 token on the Dogecoin network, with the community highlighting its ecosystem growth, potential utility from trading bots, and upcoming platform developments. Investors are actively discussing the token's correlation with the broader meme coin market cycle and the rising adoption of Doginals.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a report that the company is preparing an acquisition bid for eBay, fueling intense community speculation about how a significantly smaller firm could finance such a major deal. Investors are actively debating the potential for a transformative pivot or a complex leveraged buyout, with sentiment split between high-stakes optimism for a massive squeeze and skepticism regarding the feasibility of the acquisition.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as investors react to reports of an AI-driven autonomous lab milestone achieved using OpenAI technology, which community members are debating as a potential catalyst for long-term platform scalability. While some traders are focused on short-term price volatility and bearish sentiments regarding historical performance, others remain optimistic about the company's long-term infrastructure play in the biotechnology and AI sectors.

Chip

CHIP is seeing intense retail debate as traders weigh potential utility in the AI infrastructure sector against accusations of being a pump-and-dump scheme. The community is sharply divided, with some betting on a short squeeze and long-term holding based on upcoming token unlocks, while others cite high supply dilution and insider selling as reasons for volatility.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is drawing significant investor attention after confirming the receipt of nearly $700 million in federal tax refunds, a cash injection that analysts note exceeds the company's current market capitalization. Community discourse is heavily focused on the stock's potential for a massive short squeeze, with many users highlighting the high short interest and improved balance sheet liquidity as catalysts for a potential rally.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as members of the community weigh in on its recent performance, with active debates centered on long-term institutional utility and the potential for a recovery toward previous price levels. While some traders express frustration over extended price declines, others remain focused on technical signals and fundamental developments, frequently highlighting the network's quantum-resistant architecture and ongoing ecosystem adoption.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as investors react to a mix of strong Q4 marketplace growth and recent volatility fueled by analyst price target adjustments and debates over the impact of AI-driven delivery disruption. Community sentiment remains polarized, with active discussions focusing on the long-term sustainability of gig economy margins and whether recent analyst downgrades create a potential buying opportunity.

iShares Trust - iShares U.S. Aerospace & Defense ETF

iShares Dow Jones US Aerospace & Defense

The iShares Dow Jones US Aerospace & Defense ETF (ITA) is trending as ongoing geopolitical conflicts and shifts in defense spending keep the sector in focus for investors. The community is actively debating the potential long-term benefits of holding defense-oriented ETFs amidst persistent military demand and global supply chain challenges.

Pump.fun

Pump.fun is generating significant community conversation as traders weigh its rapid memecoin deployment against concerns over volatility and sustainability. While some participants are actively participating in buyback campaigns and promoting new projects on the platform, others remain skeptical due to the high volume of rapid token turnover and common market risks.

Based is a financial superapp built on Hyperliquid that lets users trade crypto, equities, and commodities from a single interface, fund accounts directly from bank accounts or credit cards, and spend balances at over 100 million merchants worldwide using a Visa Platinum card that converts at the point of sale with no separate off-ramp required. The platform operates across web, iOS, Android, and desktop with one account, and includes features like curated Launchpools for early project access and AI-native wallets for autonomous trading and risk monitoring.

Based Token

BASED is currently seeing active debate within the community as investors weigh its potential as a 'crypto super app' against significant volatility and concerns over leveraged trading patterns. While bulls point to technical indicators and the app's utility as signs of long-term upside, others remain skeptical, citing recurring sell-offs and warning against short-term price manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Large Growth in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling...

Equities Analysts Offer Predictions for NRXP Q1 Earnings

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 earnings estimates for NRx Pharmaceuticals in a note issued to investors on Monday...

NRx Pharmaceuticals (NASDAQ:NRXP) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $45.00 price target on shares of NRx Pharmaceuticals in a report on Monday...

NRx Pharmaceuticals (NASDAQ:NRXP) Price Target Raised to $49.00 at Ascendiant Capital Markets

Ascendiant Capital Markets lifted their price target on shares of NRx Pharmaceuticals from $48.00 to $49.00 and gave the stock a "buy" rating in a research note on Monday...

NRx Pharmaceuticals' (NRXP) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $34.00 target price on shares of NRx Pharmaceuticals in a research note on Monday...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from Analysts

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) has been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. One...

NRx Pharmaceuticals' (NRXP) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and issued a $34.00 price objective on shares of NRx Pharmaceuticals in a research report on Tuesday...

NRx Pharmaceuticals (NASDAQ:NRXP) Receives "Buy" Rating from BTIG Research

BTIG Research reaffirmed a "buy" rating and set a $25.00 target price on shares of NRx Pharmaceuticals in a research note on Tuesday...

NRx Pharmaceuticals (NASDAQ:NRXP) Releases Earnings Results, Beats Expectations By $0.28 EPS

NRx Pharmaceuticals (NASDAQ:NRXP - Get Free Report) posted its earnings results on Monday. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.09) by $0.28...

NRx Pharmaceuticals Q4 Earnings Call Highlights

NRx Pharmaceuticals (NASDAQ:NRXP) executives used the company's fourth-quarter 2025 results call to outline what they described as a "pivotal and transformative" year, highlighting advancing regulatory pathways for preservative-free ketamine and an investigational ketamine product, as well as an exp...

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

NRXP
NRX Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NRXP News

NRXPNRX Pharmaceuticals Inc